Nir Messafi

Deep Track Capital, Lp

Assets Managed

$6.124B

Holdings

Last Quarter

2026 - Q1

Filed Date

1mo 5d ago

Growth Rate

9.18%(2Q avg: 32.86%)

Sustained Growth

5 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 6.124B in assets, with a quarterly growth rate of 9.18% and a 2-quarter average growth rate of 32.86%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
XBI Spdr S&p Biotech Etf Recent Activity	20.86%	$1.277B↓ Put 10M shares@ $127.73 avg price
GH Guardant Health Inc Recent Activity Increased 19.23%	5.04%	$308.353M 3.338M shares@ $92.37 avg price	Increased 19.23%
IMVT Immunovant Inc Recent Activity	4.68%	$286.33M 11.527M shares@ $24.85 avg price
TARS Tarsus Pharmaceuticals Inc Recent Activity Increased 19.84%	4.13%	$252.54M 3.6M shares@ $70.15 avg price	Increased 19.84%
PCVX Vaxcyte Inc Recent Activity Increased 7.5%	4.09%	$249.873M 4.3M shares@ $58.11 avg price	Increased 7.5%
GPCR Structure Therapeutics Inc Recent Activity Increased 4.09%	3.37%	$206.289M 4.28M shares@ $48.21 avg price	Increased 4.09%
AXSM Axsome Therapeutics Inc Recent Activity Decreased -4.34%	3.04%	$185.922M 1.1M shares@ $169.02 avg price	Decreased -4.34%
APLS Apellis Pharmaceuticals Inc Recent Activity Decreased -41.51%	2.98%	$182.337M 4.532M shares@ $40.23 avg price	Decreased -41.51%
OCUL Ocular Therapeutix Inc Recent Activity Increased 143.94%	2.73%	$166.743M 19.686M shares@ $8.48 avg price	Increased 143.94%
VERA Vera Therapeutics Inc Recent Activity Increased 45.55%	2.7%	$165.187M 4.106M shares@ $40.23 avg price	Increased 45.55%

1-10 of 63